Like a delivery driver navigating crowded city streets, a gene-therapy-toting lipid nanoparticle faces a gauntlet of potential detours on its journey toward a cell's nucleus. First, there's entering ...
Plus: Trump has authorized businesses to conduct cyberattacks on criminals. This is today's edition of The Download, our weekday newsletter that provides a daily dose of what's going on in the world ...
The service supports a broad range of applications, including drug target identification and validation, pathway analysis, mechanistic studies and disease modelling Credit: Gorodenkoff-shutterstock ...
Scientists and biotechnology experts have called for increased investment in genetics, molecular biology and gene-editing research, saying technologies such as CRISPR could help Nigeria and other ...
For patients with blood cancers like leukemia and lymphoma, the immunotherapy known as CAR-T cell therapy can be lifesaving. Doctors remove a patient's immune cells, called T cells, engineer them in ...
Every tomato begins with a flower. But before a fruit can grow, an intricate sequence of events must happen in perfect order.
The sex reversal technique could be used to help rescue endangered species, say the researchers behind the work.
The Chosun Ilbo on MSN
CRISPR anticancer tech targets cancer mutations, spares healthy cells
A domestic research team is developing an anticancer technology that attacks DNA mutations found only in cancer cells while leaving normal cells unharmed. Unlike existing targeted anticancer drugs, ...
The CRISPR therapy, SNIPR001, was administered following a single-patient emergency investigational new drug application.
SNIPR today announced the publication of a peer-reviewed expanded access case report in Clinical Infectious Diseases describing the use of SNIPR001 in ...
MedPage Today on MSN
AI-created viruses; Taylor Farms' outbreak history; pulling a 'full Fauci'
A weekly roundup of healthcare investigations ...
SNIPR001 is SNIPR’s lead engineered CRISPR-enhanced medicine designed to selectively target E. coli. In the published case report, the patient received intravenous, topical, and intralesional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results